Cargando…
A pH-Responsive Asymmetric Microfluidic/Chitosan Device for Drug Release in Infective Bone Defect Treatment
Bacterial infection is currently considered to be one of the major reasons that leads to the failure of guided bone regeneration (GBR) therapy. Under the normal condition, the pH is neutral, while the microenvironment will become acid at the sites of infection. Here, we present an asymmetric microfl...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003349/ https://www.ncbi.nlm.nih.gov/pubmed/36902046 http://dx.doi.org/10.3390/ijms24054616 |
_version_ | 1784904585762045952 |
---|---|
author | Chen, Hongyu Tan, Wei Tong, Tianyi Shi, Xin Ma, Shiqing Zhu, Guorui |
author_facet | Chen, Hongyu Tan, Wei Tong, Tianyi Shi, Xin Ma, Shiqing Zhu, Guorui |
author_sort | Chen, Hongyu |
collection | PubMed |
description | Bacterial infection is currently considered to be one of the major reasons that leads to the failure of guided bone regeneration (GBR) therapy. Under the normal condition, the pH is neutral, while the microenvironment will become acid at the sites of infection. Here, we present an asymmetric microfluidic/chitosan device that can achieve pH-responsive drug release to treat bacterial infection and promote osteoblast proliferation at the same time. On-demand release of minocycline relies on a pH-sensitive hydrogel actuator, which swells significantly when exposed to the acid pH of an infected region. The PDMAEMA hydrogel had pronounced pH-sensitive properties, and a large volume transition occurred at pH 5 and 6. Over 12 h, the device enabled minocycline solution flowrates of 0.51–1.63 µg/h and 0.44–1.13 µg/h at pH 5 and 6, respectively. The asymmetric microfluidic/chitosan device exhibited excellent capabilities for inhibiting Staphylococcus aureus and Streptococcus mutans growth within 24 h. It had no negative effect on proliferation and morphology of L929 fibroblasts and MC3T3-E1 osteoblasts, which indicates good cytocompatibility. Therefore, such a pH-responsive drug release asymmetric microfluidic/chitosan device could be a promising therapeutic approach in the treatment of infective bone defects. |
format | Online Article Text |
id | pubmed-10003349 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100033492023-03-11 A pH-Responsive Asymmetric Microfluidic/Chitosan Device for Drug Release in Infective Bone Defect Treatment Chen, Hongyu Tan, Wei Tong, Tianyi Shi, Xin Ma, Shiqing Zhu, Guorui Int J Mol Sci Article Bacterial infection is currently considered to be one of the major reasons that leads to the failure of guided bone regeneration (GBR) therapy. Under the normal condition, the pH is neutral, while the microenvironment will become acid at the sites of infection. Here, we present an asymmetric microfluidic/chitosan device that can achieve pH-responsive drug release to treat bacterial infection and promote osteoblast proliferation at the same time. On-demand release of minocycline relies on a pH-sensitive hydrogel actuator, which swells significantly when exposed to the acid pH of an infected region. The PDMAEMA hydrogel had pronounced pH-sensitive properties, and a large volume transition occurred at pH 5 and 6. Over 12 h, the device enabled minocycline solution flowrates of 0.51–1.63 µg/h and 0.44–1.13 µg/h at pH 5 and 6, respectively. The asymmetric microfluidic/chitosan device exhibited excellent capabilities for inhibiting Staphylococcus aureus and Streptococcus mutans growth within 24 h. It had no negative effect on proliferation and morphology of L929 fibroblasts and MC3T3-E1 osteoblasts, which indicates good cytocompatibility. Therefore, such a pH-responsive drug release asymmetric microfluidic/chitosan device could be a promising therapeutic approach in the treatment of infective bone defects. MDPI 2023-02-27 /pmc/articles/PMC10003349/ /pubmed/36902046 http://dx.doi.org/10.3390/ijms24054616 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Chen, Hongyu Tan, Wei Tong, Tianyi Shi, Xin Ma, Shiqing Zhu, Guorui A pH-Responsive Asymmetric Microfluidic/Chitosan Device for Drug Release in Infective Bone Defect Treatment |
title | A pH-Responsive Asymmetric Microfluidic/Chitosan Device for Drug Release in Infective Bone Defect Treatment |
title_full | A pH-Responsive Asymmetric Microfluidic/Chitosan Device for Drug Release in Infective Bone Defect Treatment |
title_fullStr | A pH-Responsive Asymmetric Microfluidic/Chitosan Device for Drug Release in Infective Bone Defect Treatment |
title_full_unstemmed | A pH-Responsive Asymmetric Microfluidic/Chitosan Device for Drug Release in Infective Bone Defect Treatment |
title_short | A pH-Responsive Asymmetric Microfluidic/Chitosan Device for Drug Release in Infective Bone Defect Treatment |
title_sort | ph-responsive asymmetric microfluidic/chitosan device for drug release in infective bone defect treatment |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003349/ https://www.ncbi.nlm.nih.gov/pubmed/36902046 http://dx.doi.org/10.3390/ijms24054616 |
work_keys_str_mv | AT chenhongyu aphresponsiveasymmetricmicrofluidicchitosandevicefordrugreleaseininfectivebonedefecttreatment AT tanwei aphresponsiveasymmetricmicrofluidicchitosandevicefordrugreleaseininfectivebonedefecttreatment AT tongtianyi aphresponsiveasymmetricmicrofluidicchitosandevicefordrugreleaseininfectivebonedefecttreatment AT shixin aphresponsiveasymmetricmicrofluidicchitosandevicefordrugreleaseininfectivebonedefecttreatment AT mashiqing aphresponsiveasymmetricmicrofluidicchitosandevicefordrugreleaseininfectivebonedefecttreatment AT zhuguorui aphresponsiveasymmetricmicrofluidicchitosandevicefordrugreleaseininfectivebonedefecttreatment AT chenhongyu phresponsiveasymmetricmicrofluidicchitosandevicefordrugreleaseininfectivebonedefecttreatment AT tanwei phresponsiveasymmetricmicrofluidicchitosandevicefordrugreleaseininfectivebonedefecttreatment AT tongtianyi phresponsiveasymmetricmicrofluidicchitosandevicefordrugreleaseininfectivebonedefecttreatment AT shixin phresponsiveasymmetricmicrofluidicchitosandevicefordrugreleaseininfectivebonedefecttreatment AT mashiqing phresponsiveasymmetricmicrofluidicchitosandevicefordrugreleaseininfectivebonedefecttreatment AT zhuguorui phresponsiveasymmetricmicrofluidicchitosandevicefordrugreleaseininfectivebonedefecttreatment |